Press Release Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company’s Brand Name for Ibezapolstat Aug 17
Press Release Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update Aug 14